{"id":118240,"date":"2021-03-24T01:09:48","date_gmt":"2021-03-24T01:09:48","guid":{"rendered":"https:\/\/precoinnews.com\/?p=118240"},"modified":"2021-03-24T01:09:48","modified_gmt":"2021-03-24T01:09:48","slug":"cramers-lightning-round-peloton-palantir-tellurian-and-more-stocks","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/business\/cramers-lightning-round-peloton-palantir-tellurian-and-more-stocks\/","title":{"rendered":"Cramer's lightning round: Peloton, Palantir, Tellurian and more stocks"},"content":{"rendered":"
Foley Trasimene Acquisition Corp.: "There are so many of these things that it's very difficult to keep track of, and I don't want you in them. We're done with that era. I think we've got to let these stocks come down … It's too darn hard for investors."<\/p>\n
Peloton: "It's had a big run and I'm moving on."<\/p>\n
Tellurian: "It's a terrific $2 spec. I call it a call option. It's almost a lottery ticket, but I don't like betting against [co-founder] Charif Souki."<\/p>\n
Palantir: "I don't think this is the time to double down … You don't double down until something has come down significantly enough to change your [cost] basis."<\/p>\n
G1 Therapeutics: "These are stocks that I never say no to anyone, provided they recognize that it's the speculative stock in their portfolio. It is not like owning a Merck."<\/p>\n
Disclaimer<\/p>\n
Questions for Cramer?
Call Cramer: 1-800-743-CNBC<\/p>\n
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram<\/p>\n
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com<\/p>\n